India Pharmaceutical Company Anthem Biosciences India IPO to Raise $395 Million with Expected Listing on 21st July 2025, Started Operations in 2007 & Led by Ajay Bhardwaj, Ganesh Sambasivam & Ravindra KC
18th July | Hong Kong
India pharmaceutical company Anthem Biosciences India IPO has raised $395 million with expected listing on 21st July 2025. Anthem Biosciences started operations in 2007, and is led by Ajay Bhardwaj, Ganesh Sambasivam & Ravindra KC. Anthem Biosciences – Anthem Biosciences Limited (“Anthem”) is an innovation-driven and technology-focused Contract Research, Development and Manufacturing Organization (“CRDMO”) with fully integrated operations spanning across drug discovery, development and manufacturing. Anthem is one of the few companies in India with integrated New Chemical Entity (“NCE”) and New Biological Entity (“NBE”) capabilities across drug discovery, development, and commercial manufacturing. As a one-stop service provider, Anthem serves across a range of customers, encompassing innovator-focused emerging biotech and large pharmaceutical companies globally. Over its short history, since commencing operations in 2007, the company has become a powerhouse for drug and new products development and manufacture, with equal emphasis on biological and chemistry based products and services.
“ India Pharmaceutical Company Anthem Biosciences India IPO to Raise $395 Million with Expected Listing on 21st July 2025, Started Operations in 2007 & Led by Ajay Bhardwaj, Ganesh Sambasivam & Ravindra KC “
India Pharmaceutical Company Anthem Biosciences India IPO to Raise $395 Million with Expected Listing on 21st July 2025, Started Operations in 2007 & Led by Ajay Bhardwaj, Ganesh Sambasivam & Ravindra KC

Sign Up / Register
Caproasia Users
- Manage $20 million to $3 billion of assets
- Invest $3 million to $300 million
- Advise institutions, billionaires, UHNWs & HNWs
Caproasia Platforms | 11,000 Investors & Advisors
- Caproasia.com
- Caproasia Access
- Caproasia Events
- The Financial Centre | Find Services
- Membership
- Family Office Circle
- Professional Investor Circle
- Investor Relations Network
Monthly Roundtable & Networking
Family Office Programs
The 2025 Investment Day
- March - Hong Kong
- March - Singapore
- July - Hong Kong
- July - Singapore
- Sept- Hong Kong
- Sept - Singapore
- Oct- Hong Kong
- Nov - Singapore
- Visit: The Investment Day | Register: Click here
Caproasia Summits
- The Institutional Investor Summit
- The Investment / Alternatives Summit
- The Private Wealth Summit
- The Family Office Summit
- The CEO & Entrepreneur Summit
- The Capital Markets Summit
- The ESG / Sustainable Investment Summit